elizabeth loder, md, professor of neurology, harvard medical school; chief, division of headache, brigham & women's hospital.. december 2011  (17).

but shocking figures uncovered by labour yesterday show some patients are suffering agonising waits of as many as 541 days to begin treatment..

in a news release, the drug's manufacturer, amgen, said the list price will be 5 a month or ,900 annually. costs to patients may vary depending on insurance...